이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
J. B. Chemicals & Pharmaceuticals 관리
관리 기준 확인 2/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Nikhil Chopra
최고 경영자
₹65.4m
총 보상
| CEO 급여 비율 | 56.4% |
| CEO 임기 | 3.5yrs |
| CEO 소유권 | n/a |
| 경영진 평균 재임 기간 | 1.4yrs |
| 이사회 평균 재임 기간 | 3.8yrs |
최근 관리 업데이트
Recent updates
These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well
Jun 28
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Apr 19J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 09J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Dec 22We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25
Aug 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50
Feb 11Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Sep 21J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Jun 15Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50
Feb 16With EPS Growth And More, J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Interesting
Jan 27J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Could Easily Take On More Debt
Nov 30Here's Why I Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Might Deserve Your Attention Today
Sep 24Are J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Investors Paying Above The Intrinsic Value?
Aug 03Do J. B. Chemicals & Pharmaceuticals's (NSE:JBCHEPHARM) Earnings Warrant Your Attention?
Jun 14How Does J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Fare As A Dividend Stock?
May 04CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | ₹6b |
| Dec 31 2023 | n/a | n/a | ₹5b |
| Sep 30 2023 | n/a | n/a | ₹5b |
| Jun 30 2023 | n/a | n/a | ₹4b |
| Mar 31 2023 | ₹65m | ₹37m | ₹4b |
| Dec 31 2022 | n/a | n/a | ₹4b |
| Sep 30 2022 | n/a | n/a | ₹4b |
| Jun 30 2022 | n/a | n/a | ₹4b |
| Mar 31 2022 | ₹59m | ₹18m | ₹4b |
| Dec 31 2021 | n/a | n/a | ₹4b |
| Sep 30 2021 | n/a | n/a | ₹5b |
| Jun 30 2021 | n/a | n/a | ₹4b |
| Mar 31 2021 | ₹32m | ₹7m | ₹4b |
보상 대 시장: Nikhil 의 총 보상 ($USD 783.81K )은 Indian 시장( $USD 544.21K ).
보상과 수익: Nikhil 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Nikhil Chopra
3.5yrs
테뉴어
₹65,448,000
보상
Mr. Nikhil Ashokkumar Chopra serves as Chief Executive Officer and Whole-Time Director at J. B. Chemicals & Pharmaceuticals Limited since December 23, 2020 and has been its Director since May 10, 2020. He...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Whole-Time Director | 3.5yrs | ₹65.45m | 데이터 없음 | |
| President of Operations | no data | ₹23.54m | 데이터 없음 | |
| Vice President of HR & Administration | 8.4yrs | ₹11.55m | 0.00032% ₹ 872.2k | |
| Vice President of Legal | 1.3yrs | ₹1.63m | 데이터 없음 | |
| President of Global Business | no data | ₹38.85m | 0.0039% ₹ 10.5m | |
| Executive Vice President of Operations of Daman | less than a year | ₹15.54m | 0.0055% ₹ 14.9m | |
| Executive Vice President of Supply Chain Operations | 1.4yrs | ₹17.60m | 데이터 없음 | |
| Executive Vice President | less than a year | ₹14.33m | 데이터 없음 | |
| President of India Business | no data | ₹23.86m | 데이터 없음 | |
| President of R&D | no data | ₹12.34m | 데이터 없음 | |
| Executive Vice President of Operations for Ankleshwar & Panoli | 1.4yrs | ₹15.86m | 데이터 없음 | |
| Assistant Vice President | no data | ₹11.09m | 0% ₹ 0 |
1.4yrs
평균 재임 기간
47yo
평균 연령
경험이 풍부한 관리: JBCHEPHARM 의 관리팀은 경험 (평균 재직 기간 1.4 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Whole-Time Director | 3.7yrs | ₹65.45m | 데이터 없음 | |
| Chairman of Biotech Laboratories (Pty ) Ltd | no data | 데이터 없음 | 데이터 없음 | |
| Non-Executive & Independent Director | 3.8yrs | ₹7.50m | 데이터 없음 | |
| Non-Executive Director | 3.8yrs | 데이터 없음 | 데이터 없음 | |
| Non-Executive & Non-Independent Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Non-Executive Director | 3.3yrs | 데이터 없음 | 데이터 없음 | |
| Non-Executive & Independent Director | 3.8yrs | ₹7.50m | 데이터 없음 |
3.8yrs
평균 재임 기간
64.5yo
평균 연령
경험이 풍부한 이사회: JBCHEPHARM 의 이사회는 경험(평균 재직 기간 3.8 년)으로 간주됩니다.